Billen Daniel
- SEC CIK
- 0001837593
No open-market purchases or sales filed in the past year.
Current role at each company
- AUPH Aurinia Pharmaceuticals Inc.Directoras of May 22, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Billen Daniel as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 22, 2024 (view filing) | May 21 | 1 day | Billen DanielDirector | SSale | −5.25K | $5.74 | −$30.1K | −15.7%28.1K after | |
| May 23, 2023 (view filing) | May 23 | Same day | Billen DanielDirector | SSale | −4.65K | $11.26 | −$52.4K | −12.2%33.4K after |